Print Page
4213:
Hypereosinophilic Syndrome, EoE and Mastocytocis
Monday, March 5, 2018: 9:45 AM-10:45 AM
Convention Center, South Concourse, Level 1, South Hall A2
Poster Session
0.00 CME/CE
870
Systemic Mastocytosis (SM) and Mast Cell Activation Syndrome (MCAS); How Do They Differ?
Catherine Randa Weiler, MD PhD FAAAAI Rabe E Alhurani, MBBS, MS Joseph H. Butterfield, MD FAAAAI Rohit Divekar, MBBS PhD
871
Pediatric Mast Cell Activation Syndrome
Anupama Ravi, MD Jeffrey Meeusen, PhD Rohit Divekar, MBBS PhD Leslie Donato, PhD Martha F. Hartz, MD FAAAAI Joseph H. Butterfield, MD FAAAAI
872
EFFECT OF TOFACITINIB ON IGE-MEDIATED DEGRANULATION OF LAD2 HUMAN MAST CELLS AND PGD2 PRODUCTION
Arnold Kirshenbaum, MD FAAAAI Yun Bai, MS Dean D. Metcalfe, MD, FAAAAI
873
Development of a Biomarker of Pre-existing IgE Crosslinking on Human Basophils
Santiago Alvarez Arango, MD Donald W. MacGlashan, MD PhD
874
Etiologies of Severe Hypereosinophilia Evaluated in Children Hospitalized at a Tertiary Care Center
Nicholas L. Hartog, MD Avraham Beigelman, MD MSCI FAAAAI
875
Blood Eosinophil Beta1-Integrin Activation Correlates with Eosinophilic Esophagitis (EoE) Disease Activity
Mats W Johansson, PhD Michael D Evans, MS Elizabeth McKernan, BS Paul S Fichtinger, BS Evelyn L Angulo, MD Deane F Mosher, MD Shelly M Cook, MD Eric A Gaumnitz, MD Sameer K Mathur, MD PhD FAAAAI
876
Hyper-Eosinophilic Syndrome and Partial Duplication of Chromosome 21
Dikla Adir, MD Shira Benor Dror Levin David Hagin, MD
877
Soluble Siglec-8 Levels Are Detectable In Subjects With Myeloid Variant Hypereosinophilic Syndromes, But Not In Those With D816V KIT+ Systemic Mastocytosis
Fanny Legrand, PhD PharmD Yun Cao, MS Dean D. Metcalfe, MD, FAAAAI Paneez Khoury, MD FAAAAI Bruce S. Bochner, MD FAAAAI Amy D. Klion, MD
878
Myeloproliferative Hypereosinophilic Syndrome: Retrospective Analysis of Cytogenetic and Molecular Features
Thanai Pongdee, MD FAAAAI Irina Maric Paneez Khoury, MD FAAAAI Amy D. Klion, MD
879
Pediatric hypereosinophilia: characteristics, clinical manifestations and diagnoses
Dara Burris, MPH Chen E Rosenberg, MD Justin T Schwartz, MD PhD Michael Eby Juan Pablo Abonia, MD Patricia C. Fulkerson, MD PhD
880
Cardiac Manifestations of Idiopathic Hypereosinophilic Syndrome
Dayne H. Voelker, MD Jay Jin, MD PhD Thanai Pongdee, MD FAAAAI
881
Mepolizumab as a successful steroid-sparing agent in two patients with idiopathic hypereosinophilic syndrome (iHES)
Canting Guo, MD Bruce S. Bochner, MD FAAAAI
See more of: Abstracts
<< Previous Session | Next Session >>